technetium tc 99m citrate has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, A; Chakravarty, KL; Chopra, MK; Kashyap, R; Mishra, P; Mondal, A; Rawat, HS; Sharma, R | 1 |
| Bhatnagar, A; Chakravarty, K; Chopra, MK; Chuttani, K; Gupta, A; Jain, CM; Mishra, P; Mondal, A; Sharma, R | 1 |
1 trial(s) available for technetium tc 99m citrate and Bone Cancer
| Article | Year |
|---|---|
99Tcm-citrate: a new bone imaging radiopharmaceutical.
Topics: Adult; Bone and Bones; Bone Diseases; Bone Neoplasms; Citrates; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Male; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Compounds; Technetium Tc 99m Medronate; Tin Compounds; Tissue Distribution | 1999 |
1 other study(ies) available for technetium tc 99m citrate and Bone Cancer
| Article | Year |
|---|---|
Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
Topics: Adult; Bone Diseases; Bone Neoplasms; Case-Control Studies; Citrates; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Time Factors | 1998 |